AbbVie (ABBV) Cash from Operations (2016 - 2025)
AbbVie (ABBV) has disclosed Cash from Operations for 14 consecutive years, with 5218000000.0 as the latest value for Q4 2025.
- Quarterly Cash from Operations fell 25.96% to 5218000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 19030000000.0 through Dec 2025, up 1.19% year-over-year, with the annual reading at 19030000000.0 for FY2025, 1.19% up from the prior year.
- Cash from Operations for Q4 2025 was 5218000000.0 at AbbVie, down from 7024000000.0 in the prior quarter.
- The five-year high for Cash from Operations was 7935000000.0 in Q3 2021, with the low at 1635000000.0 in Q1 2025.
- Average Cash from Operations over 5 years is 5419750000.0, with a median of 5114000000.0 recorded in 2021.
- The sharpest move saw Cash from Operations plummeted 64.06% in 2024, then soared 126.9% in 2025.
- Over 5 years, Cash from Operations stood at 5075000000.0 in 2021, then surged by 46.36% to 7428000000.0 in 2022, then tumbled by 36.01% to 4753000000.0 in 2023, then skyrocketed by 48.29% to 7048000000.0 in 2024, then decreased by 25.96% to 5218000000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods came in at 5218000000.0, 7024000000.0, and 5153000000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.